BiotechTube
Home/C4 Therapeutics/Stephanie Oestreich, MBA
SO

Stephanie Oestreich, MBA

Chief Financial Officer

C4 Therapeutics

Therapeutic Areas

Oncology

C4 Therapeutics Pipeline

DrugIndicationPhase
Cemsidomide (CFT7455)Relapsed/Refractory Multiple MyelomaPhase 1/2
CFT8919EGFR L858R-mutated Non-Small Cell Lung Cancer (NSCLC)Phase 1

Leadership Team at C4 Therapeutics

AJ
Andrew J. Hirsch
Chief Executive Officer, President & Director
AC
Adam Crystal, M.D., Ph.D.
Chief Medical Officer
JD
John D. Chodera, Ph.D.
Chief Scientific Officer
ML
Marc L. Cohen
Co-Founder & Chairman of the Board
View full C4 Therapeutics profile